Although the proteomics and its applications in detecting autoimmune diseases are a prominently discussed issue, this review will focus particularly some prominent aspects regarding clinical utility of these techniques in prognosis, diagnosis, and treatment of these diseases. The impact of immunofluorescent techniques, enzyme immunoassays and use of proteomics biomarkers in the characterization of the auto immune diseases is briefly discussed. The necessity of adopting existing technologies of protein chemistry, predisposition testing, targeted monitoring and prevention of diseases through nutrition coupled with lifestyle changes will be focused as modern diagnostic tools in realizing the changeover from isolated medicine to personalized medicine. Use of biological fluids, in order to identify low abundance proteins as biomarkers in detecting autoimmune diseases is attempted in the study of serum/plasma proteomics.
Anderson, N.L. and Anderson, N.G. (1998) Proteome and Proteomics: New Technologies, New Concepts, and New Words. Electrophoresis, 19, 1853-1861. http://dx.doi.org/10.1002/elps.1150191103
Blackstock, W.P. and Weir, M.P. (1999) Proteomics: Quantitative and Physical Mapping of Cellular Proteins. Trends in Biotechnology, 17, 121-127. http://dx.doi.org/10.1016/S0167-7799(98)01245-1
James, P. (1997) Protein Identification in the Post-Genome Era: The Rapid Rise of Proteomics. Quarterly Reviews of Biophysics, 30, 279-331. http://dx.doi.org/10.1017/S0033583597003399
Abhilash, M. (2009) Applications of Proteomics. The Internet Journal of Genomics and Proteomics, 4, 1540-2630.
Xiang, Y. and Kato, T. (2006) Use of Proteomics in Analysis of Autoimmune Diseases. Lupus, 15, 431-435. www.lupus-journal.com http://dx.doi.org/10.1191/0961203306lu2329oa
Weston, A.D. and Hood, L. (2004) Systems Biology, Proteomics, and the Future of Health Care: Toward Predictive, Preventative, and Personalized Medicine. Journal of Proteome Research, 3, 179-196. http://dx.doi.org/10.1021/pr0499693
Venter, J.C., Adams, M.D., Myers, E.W., Li, P.W., Mural, R.J., Sutton, G.G., et al. (2001) The Sequence of the Human Genome. Science, 291, 1304-1351. http://dx.doi.org/10.1126/science.1058040
Lander, E.S., Linton, L.M., Birren, B., Nusbaum, C., Zody, M.C., Baldwin, J., et al. (2001) Initial Sequencing and Analysis of the Human Genome. Nature, 409, 860-921. http://dx.doi.org/10.1038/35057062
Reboul, J., Vaglio, P., Tzellas, N., Thierry-Mieg, N., Moore, T., Jackson, C., et al. (2001) Open-Reading-Frame Sequence Tags (OSTs) Support the Existence of at Least 17 300 Genes in C. elegans. Nature Genetics, 27, 332-336. http://dx.doi.org/10.1038/85913
Liebler, D.C. (2002) Introduction to Proteomics. Humana Press, New York.
Robinson, W.H., Steinman, L. and Utz, P.J. (2002) Protein and Peptide Array Analysis of Autoimmune Disease. BioTechniques, 33, 566-569.
US Department of Health and Human Services (2005) Progresses in Auto Immune Research.
Oldstone, M.B.A. (1998) Molecular Mimicry and Immune-Mediated Diseases. The FASEB Journal, 12, 1255-1265.
Croxford, J.L., Anger, H.A. and Miller, S.D. (2005) Viral Delivery of an Epitope from Haemophilus influenzae Induces Central Nervous System Autoimmune Disease by Molecular Mimicry. The Journal of Immunology, 174, 907-917. http://dx.doi.org/10.4049/jimmunol.174.2.907
Nissim, A., Winyard, P.G., Corrigall, V., Fatah, R., Perrett, D., Panayi, G. and Chernajovsky, Y. (2005) Generation of Neoantigenic Epitopes after Posttranslational Modification of Type II Collagen by Factors Present within the Inflamed Joint. Arthritis & Rheumatism, 52, 3829-3838. http://dx.doi.org/10.1002/art.21479
Hahn, M., Nicholson, M.J., Pyrdol, J. and Wucherpfennig, K.W. (2005) Unconventional Topology of Self Peptide-Major Histocompatibility Complex Binding by a Human Autoimmune T Cell Receptor. Nature Immunology, 6, 490-496. http://dx.doi.org/10.1038/ni1187
Carl, P.L., Temple, B.R. and Cohen, P.L. (2005) Most Nuclear Systemic Autoantigens Are Extremely Disordered Proteins: Implications for the Etiology of Systemic Autoimmunity. Arthritis Research & Therapy, 7, R1360. http://dx.doi.org/10.1186/ar1832
James, J. and Harley, J. (1992) Linear Epitope Mapping of an Sm B/B’ Polypeptide. The Journal of Immunology, 148, 2074-2079.
Hueber, W. and Robinson, W.H. (2006) Proteomic Biomarkers for Autoimmune Disease. Proteomics, 6, 4100-4105. http://dx.doi.org/10.1002/pmic.200600017
Prieto, S. and Grau, J.M. (2010) The Geoepidemiology of Autoimmune Muscle Disease. Autoimmunity Reviews, 9, A330-A334. http://dx.doi.org/10.1016/j.autrev.2009.11.006
Davidson, A. and Diamond, B. (2001) Autoimmune Disease. The New England Journal of Medicine, 345, 340-350. http://dx.doi.org/10.1056/NEJM200108023450506
Sherer, Y., Gorstein, A., Fritzler, M.J. and Shoenfeld, Y. (2004) Autoantibody Explosion in Systemic Lupus Erythematosus: More than 100 Different Antibodies Found in SLE Patients. Seminars in Arthritis and Rheumatism, 34, 501-537. http://dx.doi.org/10.1016/j.semarthrit.2004.07.002
Robinson, W.H., Steinman, L. and Utz, P.J. (2002) Proteomics Technologies for the Study of Autoimmune Disease. Arthritis & Rheumatism, 46, 885-893. http://dx.doi.org/10.1002/art.10129
Hueber, W., Utz, P.J., Steinman, L. and Robinson, W.H. (2002) Autoantibody Profiling for the Study of Treatment of Auto-Immune Disease. Arthritis Research & Therapy, 4, 290-295. http://dx.doi.org/10.1186/ar426
Thadikkaran, L., Siegenthaler, M.A., Crettaz, D., Queloz, P.-A., Schneider, P. and Tissot, J.-D. (2005) Recent Advances in Blood-Related Proteomics. Proteomics, 5, 3019-3034. http://dx.doi.org/10.1002/pmic.200402053
Vostry, M. (2009) Multiplex Immunoassays Chips and Beads. Electronic Journal of the IFCC, 20, No. 4.
Rados, C. (2005) Genomics and Medical Devices: A New Paradigm for Health Care. FDA Consumer, 39, 34-39. http://findarticles.com/p/articles/mi_m1370/is_6_39/ai_n27869192/
Hueber, W. and Robinson, W.H. (2009) Genomics and Proteomics: Applications in Autoimmune Diseases. Pharmacogenomics and Personalized Medicine, 2, 39-48. http://dx.doi.org/10.2147/PGPM.S4708
Ocak, S., Chaurand, P. and Massion, P.P. (2009) Mass Spectrometry-Based Proteomic Profiling of Lung Cancer. Proceedings of the American Thoracic Society, 6, 159-170. http://dx.doi.org/10.1513/pats.200809-108LC
Stoevesandt, O., Taussig, M.J. and He, M. (2009) Protein Microarrays: High-Throughput Tools for Proteomics. Expert Review of Proteomics, 6, 145-157. http://dx.doi.org/10.1586/epr.09.2
Lakhan, S.E. (2006) Schizophrenia Proteomics: Biomarkers on the Path to Laboratory Medicine? Diagnostic Pathology, 1, 11. http://dx.doi.org/10.1186/1746-1596-1-11
Walther, T.C. and Mann, M. (2010) Mass Spectrometry-Based Proteomics in Cell Biology. The Journal of Cell Biology, 190, 491-500. http://dx.doi.org/10.1083/jcb.201004052
Issaq, H.J., Xiao, Z. and Veenstra, T.D. (2007) Serum and Plasma Proteomics. Chemical Reviews, 107, 3601-3620. http://dx.doi.org/10.1021/cr068287r
Edgar, P.F., Schonberger, S.J., Dean, B., Faull, R.L., Kydd, R. and Cooper, G.J. (1999) A Comparative Proteome Analysis of Hippocampal Tissue from Schizophrenic and Alzheimer’s Disease Individuals. Molecular Psychiatry, 4, 173-178. http://dx.doi.org/10.1038/sj.mp.4000463
Master, S.R. (2005) Diagnostic Proteomics: Back to Basics? Clinical Chemistry, 51, 1333-1334. http://dx.doi.org/10.1373/clinchem.2005.053686
Conrads, T.P., Zhou, M., Petricoin III, E.F., Liotta, L. and Veenstra, T.D. (2003) Cancer Diagnosis Using Proteomic Patterns. Expert Review of Molecular Diagnostics, 3, 411-420. http://dx.doi.org/10.1586/14737159.3.4.411
Johann Jr., D.J. and Blonder, J. (2007) Biomarker Discovery: Tissues versus Fluids versus Both. Expert Review of Molecular Diagnostics, 7, 473-475. http://dx.doi.org/10.1586/14737159.7.5.473
Hortin, G.L. (2005) Can Mass Spectrometric Protein Profiling Meet Desired Standards of Clinical Laboratory Practice? Clinical Chemistry, 51, 3-5. http://dx.doi.org/10.1373/clinchem.2004.043281
Plebani, M., Pittoni, M., Celadin, M., Bernardi, D. and Mion, M.M. (2009) Recent Advances in Diagnostic Technologies for Autoimmune Diseases. Autoimmunity Reviews, 8, 238-243. http://dx.doi.org/10.1016/j.autrev.2008.07.032
Kononen, J., Bubendorf, L., Kallioniemi, A., Bärlund, M., Schraml, P., Leighton, S., Torhorst, J., Mihatsch, M.J., Sauter, G. and Kallioniemi, O.P. (1998) Tissue Microarrays for High-Throughput Molecular Profiling of Tumor Specimens. Nature Medicine, 4, 844-847. http://dx.doi.org/10.1038/nm0798-844
Pejcic, M., Stojnev, S. and Stefanovic, V. (2010) Urinary Proteomics—A Tool for Biomarker Discovery. Renal Failure, 32, 259-268. http://dx.doi.org/10.3109/08860221003599759
Proteomics, K.J. (2002) Public-Private Group Maps out Initiatives. Science, 296, 827.
Silva, J.C., Gorenstein, M.V., Li, G.Z., Vissers, J.P. and Geromanos, S.J. (2006) Absolute Quantification of Proteins by LCMSE: A Virtue of Parallel MS Acquisition. Molecular & Cellular Proteomics, 5, 144-156. http://dx.doi.org/10.1074/mcp.M500230-MCP200
Manolio, T.A. (2010) Genomewide Association Studies and Assessment of the Risk of Disease. The New England Journal of Medicine, 363, 166-176. http://dx.doi.org/10.1056/NEJMra0905980
Calzone, K., Wattendorf, D. and Dunn, B.K. (2010) The Application of Genetics and Genomics to Cancer Prevention. Seminars in Oncology, 37, 407-418. http://dx.doi.org/10.1053/j.seminoncol.2010.05.005
Cowin, P.A., Anglesio, M., Etemadmoghadam, D. and Bowtell, D.D. (2010) Profiling the Cancer Genome. Annual Review of Genomics and Human Genetics, 11, 133-159. http://dx.doi.org/10.1146/annurev-genom-082509-141536
Salamunic, I. (2010) Laboratory Diagnosis of Autoimmune Diseases—New Technologies, Old Dilemmas. Biochemia Medica, 20, 45-56. http://dx.doi.org/10.11613/BM.2010.006
Dahle, C., Skogh, T., Åberg, A.K., Jalal, A. and Olcén, P. (2004) Methods of Choice for Diagnostics Antinuclear Antibody (ANA) Screening: Benefit of Adding Antigen-Specific Assays to Immunofluorescence Microscopy. Journal of Autoimmunity, 22, 241-248. http://dx.doi.org/10.1016/j.jaut.2003.12.004
Gonzalez, C., Garcia-Berrocal, B., Talavan, T., Cassas, M.L., Navajo, J.A. and Gonzalez-Buitargo, J.M. (2005) Clinical Evaluation of a Microsphere Bead-Based Flow Cytometry Assay for the Simultaneous Determination of Anti Thyroid Peroxidase and Anti Thyroglobulin Antibodies. Clinical Biochemistry, 38, 966-972. http://dx.doi.org/10.1016/j.clinbiochem.2005.08.004
Apweiler, R., Aslandis, C., Defuel, T., Gerstner, A., Hansen, J., Hochstrasser, D., et al. (2009) Approaching Clinical Proteomics: Current State and Future Fields of Application in Fluid Proteomics. Clinical Chemistry and Laboratory Medicine, 47, 724-744. http://dx.doi.org/10.1515/CCLM.2009.167
http://lup.sagepub.com/content/15/7/431
Liu, W.L., Zhang, G., Wang, J.Y., Cao, J.Y., Guo, X.Z., et al. (2008) Proteomics-Based Identification of Autoantibody against CDC25B as a Novel Serum Marker in Esophageal Squamous Cell Carcinoma. Biochemical and Biophysical Research Communications, 375, 440-445. http://dx.doi.org/10.1016/j.bbrc.2008.08.039
Wild, N., Karl, J., Grunert, V.P., Schmitt, R.I., Garczarek, U., et al. (2008) Diagnosis of Rheumatoid Arthritis: Multivariate Analysis of Biomarkers. Biomarkers, 13, 88-105. http://dx.doi.org/10.1080/13547500701669410
Liotta, L.A. and Petricoin, E.F. (2000) Beyond the Genome to Tissue Proteomics. Breast Cancer Research, 2, 13-14. http://dx.doi.org/10.1186/bcr23
Zolg, J.W. and Langen, H. (2004) How Industry Is Approaching the Search for New Diagnostic Markers and Biomarkers. Molecular & Cellular Proteomics, 3, 345-354. http://dx.doi.org/10.1074/mcp.M400007-MCP200
Hueber, W., Kidd, B., Toomoka, B., Lee, B.-J., Bruce, B., et al. (2005) Antigen Microarray Profiling of Autoantibodies in Rheumatoid Arthritis. Arthritis & Rheumatology, 52, 2645-2655. http://dx.doi.org/10.1002/art.21269
Schellekens, G.A., de Jong, B.A., van den Hoogen, F.H., van de Putte, L.B. and van Venrooij, W.J. (1998) Citrulline Is an Essential Constituent of Antigenic Determinants Recognized by Rheumatoid Arthritis-Specific Autoantibodies. Journal of Clinical Investigation, 101, 273-281. http://dx.doi.org/10.1172/JCI1316
de Vegvar, H.E.N., Amara, R.R., Steinman, L., Utz, P.J., Robinson, H.L. and Robinson, W.H. (2003) Microarray Profiling of Antibody Responses against Simian-Human Immunodeficiency Virus: Postchallenge Convergence of Reactivities Independent of Host Histocompatibility Type and Vaccine Regimen. Journal of Virology, 77, 11125-11138. http://dx.doi.org/10.1128/JVI.77.20.11125-11138.2003
Liu, B., Qiu, F.H., Voss, C., Xu, Y., Zhao, M., Wu, Y., Nie, J. and Wang, Z. (2011) Evaluation of Three High Abundance Protein Depletion Kits for Umbilical Cord Serum Proteomics. Proteome Science, 9, 24. http://dx.doi.org/10.1186/1477-5956-9-24
Vanarsa, K. and Mohan, C. (2010) Proteomics in Rheumatology: The Dawn of a New Era. F1000 Medicine Reports, 2, 87.
Robinson, W.H., Di Gennaro, C., Hueber, W., Haab, B.B., Kamachi, M., Dean, E.J., Fournel, S., Fong, D., Genovese, M.C., Neuman de Vegvar, H.E., Skriner, K., Hirschberg, D.L., Morris, R.I., Muller, S., Pruijn, G.J., van Venrooij, W.J., Smolen, J.S., Brown, P.O., Steinman, L. and Utz, P.J. (2002) Autoantigen Microarrays for Multiplex Characterization of Autoantibody Responses. Nature Medicine, 8, 295-301. http://dx.doi.org/10.1038/nm0302-295
Pietropaolo, M. and Eisenbarth, G.S. (2001) Autoantibodies in Human Diabetes. Current Directions in Autoimmunity, 4, 252-282. http://dx.doi.org/10.1159/000060541